Nordic Nanovector competitorsClear all

Nordic Nanovector's top competitors include NeuroVive Pharmaceutical, Molecular Partners, Y-mAbs Therapeutics and ViewPoint Therapeutics.
Nordic Nanovector
Nordic Nanovector
Nordic Nanovector, a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics in hematology and oncology.
NeuroVive Pharmaceutical
NeuroVive Pharmaceutical
NeuroVive Pharmaceutical engages in the research and development of mitochondrial medicine.
Molecular Partners
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of biopharmaceutical products.
Y-mAbs Therapeutics
Y-mAbs Therapeutics
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
ViewPoint Therapeutics
ViewPoint Therapeutics
ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts.
Founding Date
Founding Date
2009
Founding Date
2000
Founding Date
2004
Founding Date
2014
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Oslo, NO HQ
Zug, CH
Shrewsbury, GB
Locations
Lund, SE HQ
Locations
Zürich-Schlieren, CH HQ
Cambridge, US
Locations
New York, US HQ
Hørsholm, DK
Nutley, US
Nutley, US
Locations
South San Francisco, US HQ
San Francisco, US
Employees
Employees
442% decrease
Employees
10
Employees
143
Employees
3239% increase
Employees
11
Valuation ($)
Valuation ($)
N/A
Valuation ($)
14.6 m
Valuation ($)
N/A
Valuation ($)
1.7 b
Valuation ($)
N/A
Alexa Website Rank
Alexa Website Rank
204242
Alexa Website Rank
356066
Alexa Website Rank
303681
Alexa Website Rank
322491
Alexa Website Rank
307801

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 10.8m
Total funding raised
N/A
Total funding raised
$ 80m
Total funding raised
$ 39m
For sources of this data, please see the company profile

View company profiles

NeuroVive Pharmaceutical
HQ
Lund, SE
Employees
10

NeuroVive Pharmaceutical engages in the research and development of mitochondrial medicine.

View company
Molecular Partners
HQ
Zürich-Schlieren, CH
Employees
143

Molecular Partners is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of biopharmaceutical products.

View company
Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase

Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.

View company
ViewPoint Therapeutics
HQ
South San Francisco, US
Employees
11

ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts.

View company